Zobrazeno 1 - 10
of 1 988
pro vyhledávání: '"PD‐1 inhibitor"'
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 11, Pp 1727-1740 (2024)
Ruixia Li,1,* Xiaohui Wang,2,* Hui Li,3 Murong Wang,3 Juncheng Wang,4 Wei Wang,5 Qunfang Zhou6 1Department of Thyroid Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, People’s Republic of Chin
Externí odkaz:
https://doaj.org/article/c55db1248a1343b09a46fae0af019a83
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 928-934 (2024)
Introduction: Chemotherapy plus immunotherapy is the standard treatment worldwide for advanced lung squamous cell carcinoma with high programmed cell death protein-1 (PD-1) expression. The use of immunotherapy alone against advanced lung squamous cel
Externí odkaz:
https://doaj.org/article/a15215f6c7f64c47a45ebf82e6813ed7
Publikováno v:
ImmunoTargets and Therapy, Vol Volume 13, Pp 399-412 (2024)
Wei Wang,1,* Ruixia Li,2,* Hui Li,3 Murong Wang,3 Juncheng Wang,4 Xiaohui Wang,5 Qunfang Zhou6 1Department of General Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, People’s Republic of China; 2Depa
Externí odkaz:
https://doaj.org/article/5f3163c68d2e4371832787acb6119728
Autor:
Evgeny L. Choynzonov, Alexander A. Fedenko, Natalia A. Falaleeva, Tatiana V. Andreeva, Sergei G. Afanas'ev, Zelimkhan A. Bakaev, Danila I. Valiev, Aleksandr A. Volkov, Larisa A. Kolomiets, Tatiana V. Krashikhina, Sergei V. Miller, Viktoriia V. Mikhaliuk, Andrei N. Ogloblin, Svetlana A. Orlova, Stanislav V. Pataliak, Ilya A. Pokataev, Nataliia O. Popova, Olesia V. Rebrina, Rustem N. Safin, Irina Iu. Stradaeva, Iuliia V. Trefilova, Inessa S. Usol'tseva, Evgenii A. Usynin, Sergey V. Sharov, Denis Iu. Iukal'chuk, Aishat R. Iasieva
Publikováno v:
Современная онкология, Vol 26, Iss 2, Pp 173-181 (2024)
Background. Post-registration observational studies with switching therapy from the original drug to a biosimilar for non-medical indications allow us to assess the safety and effectiveness of this type of switching in real clinical practice. Aim.
Externí odkaz:
https://doaj.org/article/d14ddd461b434759b7f775f2404d2a49
Autor:
Sach Thakker, BS, Mairead R. Baker, MD, Jafar Al-Mondhiry, MA, MD, Sekwon Jang, MD, Jennifer A. DeSimone, MD
Publikováno v:
JAAD International, Vol 16, Iss , Pp 130-132 (2024)
Externí odkaz:
https://doaj.org/article/97b6e22641774249a100bbd8ced540f7
Autor:
Tara C. Mitchell
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/3853a23845d640fdb0d222d768b07ee2
Autor:
ChiIeng Tou, LinFeng Ma
Publikováno v:
Radiology Case Reports, Vol 19, Iss 10, Pp 4497-4503 (2024)
Primary mediastinal large B-cell lymphoma (PMBCL) is a specific subtype of diffuse large B-cell lymphoma (DLBCL), which occurs more frequently in young women. PMBCL is an uncommon kind of cancer. R-EPOCH is a common therapeutic regimen that is suitab
Externí odkaz:
https://doaj.org/article/8dfe0799e24e451b96a2b0edbb0e4c4a
Publikováno v:
ImmunoTargets and Therapy, Vol Volume 13, Pp 305-317 (2024)
Kaiwu Xu,1 Cailing Xiang,1 Zhige Yu,1 Jia Li,2 Changjun Liu2 1Department of Gastrointestinal Surgery, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan Province, 410005, People’s Republ
Externí odkaz:
https://doaj.org/article/c4734658a00547f9b20f4a18c66c28c9
Autor:
Benjamin Kiaei, Maaria Chaudhry, Sumona Banerjee, Jonathan Brewer, Yongzhen Chen, Farid Khasiyev, Miguel A. Guzman, Ghazala Hayat
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-5 (2024)
Abstract Background Immune checkpoint inhibitors are a relatively new advancement in the world of cancer therapy. As such, their adverse effects have yet to be fully understood, with only recent literature documenting autoimmune phenomena secondary t
Externí odkaz:
https://doaj.org/article/792abcd9906e421982ed8e68e52a85d7
Publikováno v:
ImmunoTargets and Therapy, Vol Volume 13, Pp 247-258 (2024)
Wen-Bin Duan,1 Xiao-Hui Wang,2 Guo-Can Zhang,2 Zhuo He,1 Shao-Qiang Li,3 Jie Zhou1 1Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangz
Externí odkaz:
https://doaj.org/article/24c2c1189c7e4c4c9aa0280c9489e94e